Keywords: همه چیز خوب است; Basal cell carcinoma; Vulva; Lung metastasis; Hedgehog pathway; SMO inhibitors; Vismodegib;
مقالات ISI همه چیز خوب است (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: همه چیز خوب است; TAK-441 (PubChem CID: 44187367); Vismodegib (PubChem CID: 24776445); Cyclopamine (PubChem CID: 442972)Smoothened receptor; Binding kinetics; TAK-441; Vismodegib; Cyclopamine; D473H
Keywords: همه چیز خوب است; Basal cell carcinoma; Cryosurgery; Dermatologic surgery; Elderly; Electrodessication and curettage; Imiquimod; Life expectancy; Mohs surgery; Nonmelanoma skin cancer; Photodynamic therapy; Vismodegib
Vismodegib: revisión
Keywords: همه چیز خوب است; Vismodegib; Carcinoma basocelular; Vía HedgehogVismodegib; Basal cell carcinoma; Hedgehog pathway
Design, synthesis and biological evaluation of deuterated Vismodegib for improving pharmacokinetic properties
Keywords: همه چیز خوب است; Vismodegib; Hedgehog signaling pathway; Basal cell carcinoma; Deuterated drug; Deuterium-hydrogen replacement; Pharmacokinetic properties;
Combination vismodegib and photodynamic therapy for multiple basal cell carcinomas
Keywords: همه چیز خوب است; Basal cell carcinoma; BCC; Photodynamic therapy; PDT; Vismodegib;
Basal cell nevus syndrome (Gorlin syndrome): genetic insights, diagnostic challenges, and unmet milestones
Keywords: همه چیز خوب است; Gorlin syndrome; Chemopreventive agents; PTCH 1 mutation; Basal cell nevus syndrome; Odontogenic keratocyst; SUFU; Hedgehog pathway; Carnoy's solution; Vismodegib; Hedgehog signaling inhibitor; Basal cell carcinoma;
Carcinogenicity assessment of the Hedgehog pathway inhibitor, vismodegib in Tg.rasH2 mice and Sprague-Dawley rats
Keywords: همه چیز خوب است; Hedgehog; Vismodegib; Carcinogenicity; Pilomatricoma; Keratoacanthoma;
Vismodegib in patients with advanced basal cell carcinoma: Primary analysis of STEVIE, an international, open-label trial
Keywords: همه چیز خوب است; Vismodegib; Hedgehog pathway inhibitor; Basal cell carcinoma; Gorlin syndrome; STEVIE;
Possible antifibrotic effect of GDC-0449 (Vismodegib), a hedgehog-pathway inhibitor, in mice model of Schistosoma-induced liver fibrosis
Keywords: همه چیز خوب است; GDC-0449; Vismodegib; Schistosomiasis; Liver fibrosis; Hedgehog pathway;
Les nouveaux médicaments de la cancérologie
Keywords: همه چیز خوب است; antinéoplasique; bosutinib; inhibiteur de tyrosine kinase; régorafénib; thérapie ciblée; vismodegibantineoplastics; bosutinib; regorafenib; targeted therapy; tyrosine kinase inhibitor; vismodegib
Vismodegib, itraconazole and sonidegib as hedgehog pathway inhibitors and their relative competencies in the treatment of basal cell carcinomas
Keywords: همه چیز خوب است; Hedgehog pathway; Basal cell carcinoma; Metastasis; Vismodegib; Sonidegib; Itraconazole;
Carcinomes basocellulaires localement avancés : intérêt de traitements combinés, alternatifs à la chirurgie
Keywords: همه چیز خوب است; Carcinomes basocellulaires avancés; Vismodegib; Radiothérapie; Inhibiteur hedgehogAdvanced non-resectable basal-cell carcinoma; Vismodegib; Radiotherapy; Hedgehog pathway inhibitor
Smoothened (SMO) receptor mutations dictate resistance to vismodegib in basal cell carcinoma
Keywords: همه چیز خوب است; Basal cell carcinoma; Hedgehog pathway; PTCH1; SMO; Vismodegib; Primary resistance; Secondary resistance;
Pivotal ERIVANCE basal cell carcinoma (BCC) study: 12-month update of efficacy and safety of vismodegib in advanced BCC
Keywords: همه چیز خوب است; advanced basal cell carcinoma; ERIVANCE BCC study; Hedgehog pathway inhibitor; locally advanced basal cell carcinoma; metastatic basal cell carcinoma; vismodegib; AE; adverse event; BCC; basal cell carcinoma; CI; confidence interval; DOR; duration of resp
Vismodegib: A Review
Keywords: همه چیز خوب است; Vismodegib; Basal cell carcinoma; Hedgehog pathwayVismodegib; Carcinoma basocelular; Vía Hedgehog
Inhibition mechanism exploration of investigational drug TAK-441 as inhibitor against Vismodegib-resistant Smoothened mutant
Keywords: همه چیز خوب است; TAK-441; Hedgehog; Smo; Vismodegib; GDC-0449; D473H
Original articleExpanded access study of patients with advanced basal cell carcinoma treated with the Hedgehog pathway inhibitor, vismodegib
Keywords: همه چیز خوب است; basal cell carcinoma; basal cell nevus syndrome; expanded access; Hedgehog pathway inhibitor; locally advanced; metastatic; vismodegib; AE; adverse event; BCC; basal cell carcinoma; BCNS; basal cell nevus syndrome; ECOG; Eastern Cooperative Oncology Group
Toxicité dermatologique des nouvelles thérapies ciblées anticancéreuses utilisées en oncodermatologie
Keywords: همه چیز خوب است; Toxicité cutanée; Vemurafenib; Vismodegib; Selumetinib; IpilimumabSkin toxicity; Vemurafenib; Vismodegib; Selumetinib; Ipilimumab
PharmacotherapyNew drug reviewVismodegib and the Hedgehog Pathway: A New Treatment for Basal Cell Carcinoma
Keywords: همه چیز خوب است; basal cell carcinoma; Erivedge; GDC-0449; vismodegib;
Prevailing importance of the hedgehog signaling pathway and the potential for treatment advancement in sarcoma
Keywords: همه چیز خوب است; Hedgehog signaling; Sarcoma; Smoothened; Patched; Chondrosarcoma; Vismodegib
Determination of unbound vismodegib (GDC-0449) concentration in human plasma using rapid equilibrium dialysis followed by solid phase extraction and high-performance liquid chromatography coupled to mass spectrometry
Keywords: همه چیز خوب است; Vismodegib; GDC-0449; Hedgehog pathway inhibitor; RED device; LC–MS/MS